BIOGEN INC. Number of Reportable Segments
BIOGEN INC. (BIIB) reported Number of Reportable Segments of 1 segment for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-04-29
- BIOGEN INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- BIOGEN INC. number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment, a 0.00% change year-over-year.
- BIOGEN INC. number of reportable segments for the quarter ending 2024-03-31 was 1.00 segment, a 0.00% change year-over-year.
- BIOGEN INC. number of reportable segments for the quarter ending 2023-03-31 was 1.00 segment, a 0.00% change year-over-year.
- BIOGEN INC. number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- BIOGEN INC. number of reportable segments for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
- BIOGEN INC. number of reportable segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- BIOGEN INC. number of reportable segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-04-29 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-06 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-10-30 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-07-31 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-12 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-10-30 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-01 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-04-24 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-14 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-07-25 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-04-25 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-02-15 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-10-25 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-07-20 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-03 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-03 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-10-20 | |||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-07-22 | |||
| 2021-03-31 | 1.00 segment 10-Q · filed 2021-04-22 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-02-03 | |||
| 2020-09-30 | 1.00 segment 10-Q · filed 2020-10-21 | |||
| 2020-06-30 | 1.00 segment 10-Q · filed 2020-07-22 | |||
| 2020-03-31 | 1.00 segment 10-Q · filed 2020-04-23 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-02-06 | |||
| 2019-09-30 | 1.00 segment 10-Q · filed 2019-10-22 | |||
| 2019-06-30 | 1.00 segment 10-Q · filed 2019-07-24 | |||
| 2019-03-31 | 1.00 segment 10-Q · filed 2019-04-24 | |||
| 2018-12-31 | 1.00 segment 10-K · filed 2019-02-06 | |||
| 2018-09-30 | 1.00 segment 10-Q · filed 2018-10-23 | |||
| 2018-06-30 | 1.00 segment 10-Q · filed 2018-07-24 | |||
| 2018-03-31 | 1.00 segment 10-Q · filed 2018-04-24 | |||
| 2017-12-31 | 1.00 segment 10-K · filed 2018-02-01 | |||
| 2017-09-30 | 1.00 segment 10-Q · filed 2017-10-24 | |||
| 2017-06-30 | 1.00 segment 10-Q · filed 2017-07-25 | |||
| 2017-03-31 | 1.00 segment 10-Q · filed 2017-04-25 | |||
| 2016-12-31 | 1.00 segment 10-K · filed 2017-02-02 | |||
| 2016-09-30 | 1.00 segment 10-Q · filed 2016-10-26 | |||
| 2016-06-30 | 1.00 segment 10-Q · filed 2016-07-21 | |||
| 2016-03-31 | 1.00 segment 10-Q · filed 2016-04-21 | |||
| 2015-12-31 | 1.00 segment 10-K · filed 2016-02-03 | |||
| 2015-09-30 | 1.00 segment 10-Q · filed 2015-10-21 | |||
| 2015-06-30 | 1.00 segment 10-Q · filed 2015-07-24 | |||
| 2015-03-31 | 1.00 segment 10-Q · filed 2015-04-24 | |||
| 2014-12-31 | 1.00 segment 10-K · filed 2015-02-04 | |||
| 2014-09-30 | 1.00 segment 10-Q · filed 2014-10-22 | |||
| 2014-06-30 | 1.00 segment 10-Q · filed 2014-07-23 | |||
| 2014-03-31 | 1.00 segment 10-Q · filed 2014-04-23 | |||
| 2013-12-31 | 1.00 segment 10-K · filed 2014-02-06 | |||
| 2013-09-30 | 1.00 segment 10-Q · filed 2013-10-28 | |||
| 2013-06-30 | 1.00 segment 10-Q · filed 2013-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |